The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AADI BIOSCIENCES INC | COM | 00032Q104 | 19,622,228 | 1,849,402 | SH | SOLE | 1,849,402 | 0 | 0 | ||
ACLARIS THERAPEUTICS | COM | 00461U105 | 4,016,250 | 255,000 | SH | SOLE | 255,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 11,246,925 | 217,500 | SH | SOLE | 217,500 | 0 | 0 | ||
ARGEN SE | SPONSORED ADR | 04016X101 | 1,932,033 | 5,100 | SH | SOLE | 5,100 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS INC | COM | 04280A100 | 1,664,136 | 41,029 | SH | SOLE | 41,029 | 0 | 0 | ||
BELLUS HEALTH INC | COM NEW | 07987C204 | 5,199,150 | 632,500 | SH | SOLE | 632,500 | 0 | 0 | ||
BIOATLA INC | COM | 09077B104 | 4,125,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC | COM NEW | 15117B202 | 5,125,550 | 115,000 | SH | SOLE | 115,000 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC. COMMON STOCK | COM | 23257D103 | 6,364,050 | 1,015,000 | SH | SOLE | 1,015,000 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 1,061,886 | 303,396 | SH | SOLE | 303,396 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 1,346,800 | 185,000 | SH | SOLE | 185,000 | 0 | 0 | ||
GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 2,364,390 | 243,250 | SH | SOLE | 243,250 | 0 | 0 | ||
HORIZON THERAPEUTICS PLC | SHS | G46188101 | 682,800 | 6,000 | SH | SOLE | 6,000 | 0 | 0 | ||
IMARA INC | COM | 45249V107 | 182,017 | 44,503 | SH | SOLE | 44,503 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 981,753 | 153,639 | SH | SOLE | 153,639 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 7,718,305 | 360,500 | SH | SOLE | 360,500 | 0 | 0 | ||
KEROS THERAPEUTICS INC | COM | 492327101 | 3,841,600 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
KINNATE BIOPHARMA INC | COM | 49705R105 | 30,500 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
KURA ONCOLOGY INC. COMMON STOCK | COM | 50127T109 | 6,223,615 | 501,500 | SH | SOLE | 501,500 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 5,567,000 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 981,750 | 93,500 | SH | SOLE | 93,500 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/2027 | 67080N119 | 13,125 | 90,832 | SH | SOLE | 90,832 | 0 | 0 | ||
PMV PHARMACEUTICALS INC | COM | 69353Y103 | 1,343,898 | 154,471 | SH | SOLE | 154,471 | 0 | 0 | ||
PROTHENA CORPORATION PLC | SHS | G72800108 | 560,325 | 9,300 | SH | SOLE | 9,300 | 0 | 0 | ||
PYXIS ONCOLOGY INC | COMMON STOCK | 747324101 | 896,672 | 669,158 | SH | SOLE | 669,158 | 0 | 0 | ||
REZOLUTE INC | COM NEW | 76200L309 | 869,400 | 420,000 | SH | SOLE | 420,000 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 5,088,200 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | ||
SAREPTA TEHRAPEUTICS INC | COM | 803607100 | 8,746,650 | 67,500 | SH | SOLE | 67,500 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 8,261,426 | 324,614 | SH | SOLE | 324,614 | 0 | 0 | ||
TERNS PHARMACEUTICALS INC | COM | 880881107 | 11,198,000 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 9,176,970 | 33,000 | SH | SOLE | 33,000 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 6,928,775 | 144,500 | SH | SOLE | 144,500 | 0 | 0 | ||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 7,558,095 | 290,500 | SH | SOLE | 290,500 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 11,581,765 | 396,500 | SH | SOLE | 396,500 | 0 | 0 |